FGF protection and inhibition of human neutrophil elastase by carboxymethyl benzylamide sulfonate dextran derivatives
- 29 February 1996
- journal article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 18 (1-2) , 141-145
- https://doi.org/10.1016/0141-8130(95)01074-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- New Approaches to Tissue Regeneration and RepairPathology - Research and Practice, 1994
- Heparin and its Derivatives Modulate Serine Proteinases (SERPS) Serine Proteinase Inhibitors (SERPINS) BalancePathology - Research and Practice, 1994
- Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparinBiochemical Pharmacology, 1993
- Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGFJournal of Cellular Physiology, 1992
- Biological and binding studies of acidic fibroblast growth factor in the presence of substituted dextranJournal of Biomaterials Science, Polymer Edition, 1989
- Inhibition of leucocyte elastase by heparin and its derivativesBiochemical Journal, 1988
- Elastase in Tissue InjuryAnnual Review of Medicine, 1985
- Anticoagulant activity of dextran derivatives. Part I: Synthesis and characterizationBiomaterials, 1984
- The Specific Velocity PlotEuropean Journal of Biochemistry, 1981
- Analytical description of the effects of modifiers and of enzyme multivalency upon the steady state catalyzed reaction rateTransactions of the Faraday Society, 1953